Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 26, 2009

Premium

Luminex has elected four Class III members to serve three-year terms on its board of directors. The company elected Patrick Balthrop, company president and CEO; Walter Lowenbaum, chairman and CEO of Mumboe and chairman of Luminex; and Kevin McNamara, director of Tyson Foods.

The company also has elected Edward Ogunro to serve as an independent director. Ogunro also serves on the board of Applied Neurosolutions, and he was a senior executive at Hospira.


Bob Michitarian will manage Levin & Co.'s national legal recruiting and consulting practice, the Boston law firm said last week.

Michitarian joined Levin & Co. in December 2008 as managing director. He previously served as vice president and general counsel at CoTherix, a South San Francisco, Calif.-based pharmaceutical company. He also held positions at Affymetrix, Genentech, and Latham & Watkins.


Carl Hull, who has succeeded Henry Nordhoff as CEO at Gen-Probe, has reached a contract agreement with the company. Under the agreement, Hull will receive an annual base salary of $635,000 and a bonus of around 75 percent of that salary, depending on the determination of the company's board of directors.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.